| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Guangdong Redwall New Materials Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥8.24 |
| 52 Week High | CN¥11.32 |
| 52 Week Low | CN¥6.16 |
| Beta | 0.34 |
| 1 Month Change | -6.68% |
| 3 Month Change | -0.60% |
| 1 Year Change | -16.00% |
| 3 Year Change | -18.09% |
| 5 Year Change | -19.49% |
| Change since IPO | -35.03% |
Recent News & Updates
Shareholder Returns
| 2809 | CN Chemicals | CN Market | |
|---|---|---|---|
| 7D | 6.5% | 4.8% | 4.2% |
| 1Y | -16.0% | -18.0% | -13.2% |
Return vs Industry: 002809 exceeded the CN Chemicals industry which returned -18% over the past year.
Return vs Market: 002809 underperformed the CN Market which returned -13.2% over the past year.
Price Volatility
| 2809 volatility | |
|---|---|
| 2809 Average Weekly Movement | 8.9% |
| Chemicals Industry Average Movement | 8.7% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 002809 has not had significant price volatility in the past 3 months.
Volatility Over Time: 002809's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 713 | Lian Jun Liu | www.redwall.com.cn |
Guangdong Redwall New Materials Co., Ltd. engages in the research and development, production, and sale of concrete admixtures in China and internationally. It offers polycarboxylate, naphthalene derivatives and collapse, polycarboxylic acid collapse; sodium gluconate, aliphatic, defoamer, waterproof, antifreeze, plastic retention, and air entraining agents; and gypsum board superplasticizer.
Guangdong Redwall New Materials Co., Ltd. Fundamentals Summary
| 2809 fundamental statistics | |
|---|---|
| Market cap | CN¥1.73b |
| Earnings (TTM) | CN¥77.84m |
| Revenue (TTM) | CN¥722.34m |
22.3x
P/E Ratio2.4x
P/S RatioIs 2809 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2809 income statement (TTM) | |
|---|---|
| Revenue | CN¥722.34m |
| Cost of Revenue | CN¥482.41m |
| Gross Profit | CN¥239.94m |
| Other Expenses | CN¥162.09m |
| Earnings | CN¥77.84m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.37 |
| Gross Margin | 33.22% |
| Net Profit Margin | 10.78% |
| Debt/Equity Ratio | 34.8% |
How did 2809 perform over the long term?
See historical performance and comparison